Annotation Detail for ST3GAL3
Basic Information
Top
| Pathway ID | Pathway Name |
|---|
| hsa00601 | Glycosphingolipid biosynthesis - lacto and neolacto series |
| hsa00533 | Glycosaminoglycan biosynthesis - keratan sulfate |
| hsa01100 | Metabolic pathways |
| Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
|---|
| C016403 |
2,4-dinitrotoluene |
2,4-dinitrotoluene affects the expression of ST3GAL3 mRNA | affects expression | 21346803
|
| D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of ST3GAL3 mRNA | affects expression | 16483693
|
| Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
|---|
| MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
4.44 | 18287403 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,4-dinitrotoluene |
1.79 | 16705839 |
| MESH:D003490 |
Cyanosis |
|
2,4-dinitrotoluene |
4.78 | 18551238 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
2,4-dinitrotoluene |
2.06 | 18551238 21346803 |
| MESH:D007680 |
Kidney Neoplasms |
|
2,4-dinitrotoluene |
3.41 | 16705839 |
| MESH:D009336 |
Necrosis |
|
2,4-dinitrotoluene |
4.74 | 18551238 |
| MESH:D009784 |
Occupational Diseases |
|
2,4-dinitrotoluene |
3.93 | 12819281 16049721 |
| MESH:D012640 |
Seizures |
|
2,4-dinitrotoluene |
2.85 | 18551238 |
| MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,4-dinitrotoluene |
2.43 | 16049721 |
| MESH:D014571 |
Urologic Neoplasms |
|
2,4-dinitrotoluene |
5.20 | 10091137 |
| Pathway ID |
Pathway Name |
|---|
| KEGG:00533 |
Glycosaminoglycan biosynthesis - keratan sulfate |
| KEGG:00601 |
Glycosphingolipid biosynthesis - lacto and neolacto series |
| KEGG:01100 |
Metabolic pathways |
| KEGG:00514 |
Other types of O-glycan biosynthesis |
Related Diseases/Disorders